首页> 美国卫生研究院文献>PLoS Clinical Trials >Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging
【2h】

Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging

机译:Gd-EOB-DTPA增强肝磁共振成像检查质子束治疗肝癌后局灶性肝反应的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundProton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), and toxicity tends to be lower than for photon radiotherapy. Focal liver parenchymal damage in radiotherapy is described as the focal liver reaction (FLR); the threshold doses (TDs) for FLR in the background liver have been analyzed in stereotactic ablative body radiotherapy and brachytherapy. To develop a safer approach for PBT, both TD and liver volume changes are considered clinically important in predicting the extent of damage before treatment, and subsequently in reducing background liver damage. We investigated appearance time, TDs and volume changes regarding FLR after PBT for HCC.
机译:背景质子束治疗(PBT)对肝细胞癌(HCC)达到了良好的局部控制,并且毒性往往比光子放疗低。放射治疗中的局灶性肝实质损害被称为局灶性肝反应(FLR)。在立体定向消融身体放疗和近距离放射治疗中对背景肝脏中FLR的阈值剂量(TDs)进行了分析。为了开发一种更安全的PBT方法,在预测治疗前的损害程度并随后减少背景肝损害方面,TD和肝脏体积的变化在临床上均具有重要意义。我们调查了HCC PBT后FLR的出现时间,TD和体积变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号